Assessment of safety of self-controlled repetitive trans-vertebral magnetic stimulation.


Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
12 2021
Historique:
received: 20 11 2020
revised: 26 08 2021
accepted: 14 09 2021
pubmed: 11 11 2021
medline: 21 12 2021
entrez: 10 11 2021
Statut: ppublish

Résumé

The aim of this study was to assess safety issues of self-controlled repetitive trans-vertebral magnetic stimulation (rTVMS) in humans. We investigated effects of self-controlled rTVMS (≤20 Hz, ≤90% intensity) on vital signs and subjective sensations in 1690 trials of 30 healthy volunteers and 12 patients with spinal cord disorders. Healthy volunteers and the patients received 4595 ± 2345, and 4450 ± 2304 pulses in one day, respectively. No serious adverse events were observed in any participants, and only minor events were seen as follows. While blood pressure was unaffected in the patients, the diastolic blood pressure increased slightly after rTVMS in healthy volunteers. The peripheral capillary oxygen saturation increased after rTVMS in healthy volunteers. "Pain" or "Discomfort" was reported in approximately 10% of trials in both participants groups. Degree of the evoked sensation positively correlated with stimulus intensity and was affected by the site of stimulation. Self-controlled rTVMS (≤20 Hz and ≤90% intensity) did not induce any serious adverse effects in healthy volunteers and patients with spinal cord disorders. Our results indicate that rTVMS can be used safely in physiological investigations in healthy volunteers and also as treatment for neurological disorders.

Identifiants

pubmed: 34758417
pii: S1388-2457(21)00763-X
doi: 10.1016/j.clinph.2021.09.016
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3166-3176

Informations de copyright

Copyright © 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Syusaku Sasada (S)

Department of Developmental Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi, Japan; Department of Food and Nutrition Science, Sagami Women's University, Kanagawa, Japan.

Suguru Kadowaki (S)

Department of Neurology, Ohta General Hospital, Fukushima, Japan.

Toshiki Tazoe (T)

Neural Prosthetics Project, Department of Neuroscience, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

Takashi Murayama (T)

Rehabilitation Therapy, Chiba Rehabilitation Center, Chiba, Japan.

Kenji Kato (K)

Department of Developmental Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi, Japan.

Yaoki Nakao (Y)

Department of Developmental Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi, Japan.

Hideyuki Matsumoto (H)

Department of Neurology, Mitsui Memorial Hospital, Tokyo, Japan.

Yukio Nishimura (Y)

Department of Developmental Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi, Japan; Neural Prosthetics Project, Department of Neuroscience, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan; Department of Physiological Sciences, School of Life Science, The Graduate University for Advanced Studies, SOKENDAI, Japan. Electronic address: nishimura-yk@igakuken.or.jp.

Yoshikazu Ugawa (Y)

Department of Human Neurophysiology, School of Medicine, Fukushima Medical University, Fukushima, Japan. Electronic address: ugawa-tky@umin.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH